(-0.03%) 5 467.43 points
(0.14%) 39 166 points
(0.16%) 17 746 points
(0.00%) $80.83
(-5.04%) $2.62
(-0.86%) $2 310.80
(-0.24%) $28.80
(3.13%) $1 017.30
(0.33%) $0.936
(0.73%) $10.68
(0.51%) $0.792
(-0.29%) $87.24
-6.97% $ 8.54
Live Chart Being Loaded With Signals
Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States...
Stats | |
---|---|
Volumen de hoy | 98 872 |
Volumen promedio | 528 916 |
Capitalización de mercado | 234.86M |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.105 (1.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-06-08 | Harshbarger Benjamin | Buy | 200 000 | Stock Option (right to buy) |
2021-06-02 | Callori Fred | Buy | 85 000 | Stock Option (right to buy) |
2021-06-02 | Violin Jonathan | Buy | 85 000 | Stock Option (right to buy) |
2021-06-02 | Clauser Noah | Buy | 600 000 | Stock Option (right to buy) |
2021-06-02 | Kishbauch Michael D | Buy | 100 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 86 transactions |
Buy: 7 288 895 | Sell: 328 827 |
Volumen Correlación
Catabasis Pharmaceuticals Correlación
10 Correlaciones Más Negativas | |
---|---|
MLHR | -0.814 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Catabasis Pharmaceuticals Correlación - Moneda/Commodity
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. Its lead product candidate is edasalonexent, an oral small molecule that inhibits nuclear factor kappa-light-chain-enhancer of activated B cells, which is in Phase III clinical trial for the treatment of duchenne muscular dystrophy (DMD). The company is also developing CAT-5571 for the treatment of cystic fibrosis. Catabasis Pharmaceuticals, Inc. has a preclinical research collaboration with the Jain Foundation to study edasalonexent in dysferlinopathy; and an agreement with the Bill & Melinda Gates Medical Research Institute to study CAT-5571 in drug-sensitive and drug-resistant tuberculosis. The company was founded in 2008 and is based in Boston, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico